mylife system and Dexcom's CGM

Ypsomed partners with Dexcom

mylife Stories

We have recently entered a partnership with Dexcom to improve your diabetes therapy system. This partnership will make it possible for you to use the Dexcom G6 CGM system as part of the mylife Diabetescare therapy system. Thanks to this integration, you will be able to review mylife YpsoPump insulin data as well as Dexcom’s continuous glucose monitoring data in your mylife App on your smartphone.

Burgdorf/San Diego – Ypsomed (SWX:YPSN) and DexCom Inc. (NASDAQ:DXCM), the world's leading provider of continuous glucose monitoring (CGM) systems, announce their partnership to drive development of a hybrid closed loop system. The partnership is an important milestone in the further development of individualised diabetes therapy. In a first step, CGM data from Dexcom will be integrated into the mylife App from Ypsomed.

Individualisation in diabetes therapy

mylife Stories

The number of Type 1 diabetics using old insulin pumps without secure communication interfaces to build their own “Closed Loop” system is growing steadily. The so-called “loopers” are thus sending a clear signal to manufacturers and showing what is in demand for insulin pump therapy.